|
Written by Allen Lawrence, M.D.
|
|
Tuesday, 13 January 2009 |
 After Further Review, Vytorin Gets FDA OK
Regulatory Agency Says Patients Should Not Stop Taking Vytorin Or Other Cholesterol Drugs
The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales.
To read the full article After Further Review, Vytorin Gets FDA OK, click here.
|
|
Last Updated ( Tuesday, 13 January 2009 )
|
